These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32878556)

  • 1. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
    Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
    Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkish lupusPRO: cross-cultural validation study for lupus.
    Kaya A; Goker B; Cura ES; Tezcan ME; Tufan A; Mercan R; Bitik B; Haznedaroglu S; Ozturk MA; Mikolaitis-Preuss RA; Block JA; Jolly M
    Clin Rheumatol; 2014 Aug; 33(8):1079-84. PubMed ID: 23934384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.
    Pinto B; Jolly M; Dhooria A; Grover S; Raj JM; Devilliers H; Sharma A
    Lupus; 2019 Nov; 28(13):1534-1540. PubMed ID: 31635557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus.
    Mok CC; Kosinski M; Ho LY; Chan KL; Jolly M
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):297-304. PubMed ID: 25156199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus.
    Han JY; Cho SK; Nam E; Kim H; Lee SS; Jolly M; Sung YK
    Lupus; 2022 Oct; 31(12):1498-1507. PubMed ID: 36017605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
    Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
    Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines.
    Navarra SV; Tanangunan RM; Mikolaitis-Preuss RA; Kosinski M; Block JA; Jolly M
    Lupus; 2013 Mar; 22(3):262-7. PubMed ID: 23340995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.
    Bourré-Tessier J; Clarke AE; Kosinski M; Mikolaitis-Preuss RA; Bernatsky S; Block JA; Jolly M
    Lupus; 2014 Dec; 23(14):1452-9. PubMed ID: 25081500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish LupusPRO: cross-cultural validation study for lupus.
    Jolly M; Toloza S; Block J; Mikolaitis R; Kosinski M; Wallace D; Durran-Barragan S; Bertoli A; Blazevic I; Vilá L; Cooray D; Moldovan I; Katsaros E; Weisman M; Torralba KM; Alarcón G
    Lupus; 2013 Apr; 22(5):431-6. PubMed ID: 23554032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.
    Inoue M; Shiozawa K; Yoshihara R; Yamane T; Shima Y; Hirano T; Jolly M; Makimoto K
    Lupus; 2017 Jul; 26(8):849-856. PubMed ID: 27927882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation and validation of Systemic Lupus Erythematosus Quality of Life questionnaire into Arabic.
    Aziz MM; Galal MAA; Elzohri MH; El-Nouby F; Leong KP
    Lupus; 2018 Apr; 27(5):780-787. PubMed ID: 29308728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Lupus Impact Tracker in an Australian patient cohort.
    Antony A; Kandane-Rathnayake RK; Ko T; Boulos D; Hoi AY; Jolly M; Morand EF
    Lupus; 2017 Jan; 26(1):98-105. PubMed ID: 27516435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life.
    Doi H; Ohmura K; Tabuchi Y; Hashimoto M; Takase Y; Inaba R; Kozuki T; Iwasaki T; Taniguchi M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Yoshifuji H; Yamamoto W; Tanaka M; Akio M
    Lupus; 2021 Jun; 30(7):1108-1115. PubMed ID: 33779381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings.
    Schneider M; Mosca M; Pego-Reigosa JM; Gunnarsson I; Maurel F; Garofano A; Perna A; Porcasi R; Devilliers H
    Rheumatology (Oxford); 2017 May; 56(5):818-828. PubMed ID: 28204765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.
    Jolly M; Sequeira W; Block JA; Toloza S; Bertoli A; Blazevic I; Vila LM; Moldovan I; Torralba KD; Mazzoni D; Cicognani E; Hasni S; Goker B; Haznedaroglu S; Bourre-Tessier J; Navarra SV; Mok CC; Weisman M; Clarke AE; Wallace D; Alarcón G
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1647-1652. PubMed ID: 29693320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study.
    Baba S; Katsumata Y; Okamoto Y; Kawaguchi Y; Hanaoka M; Kawasumi H; Yamanaka H
    Lupus; 2018 Mar; 27(3):407-416. PubMed ID: 28795653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus.
    Azizoddin DR; Olmstead R; Cost C; Jolly M; Ayeroff J; Racaza G; Sumner LA; Ormseth S; Weisman M; Nicassio PM
    Lupus; 2017 Aug; 26(9):967-974. PubMed ID: 28059025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.